ENDOGEN ApS
CVR 29813337 · Private limited company (ApS) · Active · Low risk
ENDOGEN ApS is a Private limited company (ApS), founded on , based in Aarhus C. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 17 annual reports have been published. The latest annual report (26 Oct 2025) shows equity of DKK -82k and a net result of DKK -79k. CEO: Simon Glerup Pedersen.
Bankruptcy risk for ENDOGEN ApS
0.4 × the average (1.41%) · higher risk than 66% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 29813337
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (18 years)
- Address
- c/o Kitchen/Simon Glerup Pedersen, Universitetsbyen 76
8000 Aarhus C - Municipality
- Aarhus
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 154k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 17 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -56.7% |
| Current ratio | 345% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 12 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 113k | DKK -15k |
| Net profit | DKK -79k | DKK -23k |
| Equity | DKK -82k | DKK -2,928 |
| Total assets | DKK 145k | DKK 129k |
| Cash | DKK 59k | – |
| Short-term debt | DKK 21k | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 27 Oct 2024 – 26 Oct 2025 | 107 | ||
| 27 Oct 2023 – 26 Oct 2024 | 167 | ||
| 27 Oct 2022 – 26 Oct 2023 | 128 | ||
| 27 Oct 2021 – 26 Oct 2022 | 75 | ||
| 27 Oct 2020 – 26 Oct 2021 | 83 | ||
| 27 Oct 2019 – 26 Oct 2020 | 151 | ||
| 27 Oct 2018 – 26 Oct 2019 | 86 | ||
| 27 Oct 2017 – 26 Oct 2018 | 150 | ||
| 27 Oct 2016 – 26 Oct 2017 | 132 | ||
| 27 Oct 2015 – 26 Oct 2016 | 151 | ||
| 27 Oct 2014 – 26 Oct 2015 | 152 | ||
| 27 Oct 2013 – 26 Oct 2014 | 121 | ||
| 27 Oct 2012 – 26 Oct 2013 | 139 | ||
| 27 Oct 2011 – 26 Oct 2012 | 167 | ||
| 27 Oct 2010 – 26 Oct 2011 | 179 | ||
| 27 Oct 2009 – 26 Oct 2010 | 148 | ||
| 27 Oct 2008 – 26 Oct 2009 | 149 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Simon Glerup Pedersen | Current | |
| Owner (33%) | Camilla Gustafsen Consulting ApS | Current | |
| Owner (33%) | Simon Glerup Consulting ApS | Current | |
| Owner (15%) | KOLLISION ApS | Current | |
| Owner (25%) | Simon Glerup Pedersen | ||
| Owner (25%) | Camilla Gustafsen | ||
| Owner (25%) | Simon Mølgaard Jensen | ||
| Owner (33%) | Camilla Gustafsen Consulting ApS | ||
| Owner (33%) | Simon Glerup Consulting ApS | ||
| Owner (33%) | IMAS Holding ApS | ||
| Owner (25%) | Camilla Gustafsen | ||
| Owner (25%) | Simon Glerup Pedersen | ||
| Owner (25%) | Simon Mølgaard Jensen | ||
| Owner (10%) | KOLLISION ApS | ||
| Owner (25%) | Camilla Gustafsen Consulting ApS | ||
| Owner (25%) | Simon Glerup Consulting ApS | ||
| Owner (25%) | IMAS Holding ApS | ||
| Founder | Ib Glerup Nielsen | Current | |
| Founder | Simon Glerup Pedersen | Current |
The CEOs' other companies
Simon Glerup Pedersen – 3 other companies
- Draupnir Bio ApS Active
- Muna Therapeutics ApS Active
- Simon Glerup Consulting ApS Active
Address history (4 moves)
| c/o Kitchen/Simon Glerup Pedersen, Universitetsbyen 76, 8000 Aarhus C | |
| c/o The Kitchen/Simon Glerup Pedersen, Universitetsbyen 14, 8000 Aarhus C | |
| c/o Simon Glerup Pedersen, Lerbækvej 9, 8240 Risskov | |
| c/o Simon Glerup Pedersen, Solsikkevej 8, 8240 Risskov | |
| c/o Simon Glerup Pedersen, Agerbæksvej 5, 8240 Risskov |
Other companies at the same address
- CAPNOVA A/S Active
- EntoPrime ApS Active
- EquityLook ApS Active
- Heart2Heart ApS Active
- Krydr ApS Active
- Mile Sports ApS Active
- MultiBiopsy ApS Active
- Potato Patrol ApS Active
- Rentz Holding ApS Active
- Sofina Holding ApS Active
- Wenemea ApS Active
- abeba ApS Active
Similar companies in Aarhus
- Resiliency Centre ApS Aarhus N
- SymbioMatch ApS Aarhus C
- AptaShape ApS Aarhus C
- Aptamist ApS Lystrup
- Mmimetika ApS Aarhus N
- MKR Finans APS Aarhus C
- Cystotech ApS Aarhus C
- IMCOR ApS Egå
- Commit Biologics ApS Aarhus C
- Økologisk Komplementarselskab ApS Aarhus N
- MyGold ApS Aarhus C
- UNIKUM Therapeutics ApS Risskov
Questions and answers about ENDOGEN ApS
Has ENDOGEN ApS gone bankrupt?
No, ENDOGEN ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of ENDOGEN ApS?
Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of ENDOGEN ApS?
Simon Glerup Pedersen is the CEO of ENDOGEN ApS.
When was ENDOGEN ApS founded?
ENDOGEN ApS was founded on 27 October 2008.
What is the equity of ENDOGEN ApS?
Equity was DKK -82k according to the annual report for the period ending 26 October 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.